meitshel

GRTS - Potential Gap Play

Long
meitshel Aktualisiert   
NASDAQ:GRTS   Gritstone bio, Inc.
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Disclaimer: This content is for informational purposes only and is not intended as financial advice.

Upcoming Catalyst:

Date: 3Q 2024
Details: Anticipating a potential pre-run-up leading to the data release.

Investment Overview (Dated 03/05/2024):

Relative Volume: 1.51
Shares Float: 97.27 million
Short Float: 13.16%

Key Technical Levels:

Potential Gap Fill: Above $1.00 needs to break for confirmation.

Resistance Levels: Look for resistance at $1.40, $1.80, and $2.05. Breaking above these levels could indicate an upward trend. Taking partial profits at these points might secure gains.

Trading Strategy:

Take Profit (TP): Target a profit at $2.20 to achieve a full gap fill.

Stop Loss (SL): Set a stop loss below $0.80 to minimize potential losses.

Chart Analysis:

Refer to the accompanying chart for a comprehensive analysis of price movements and trend lines.

Trading Caution:

Trade with careful consideration of market conditions and personal risk tolerance.
Conduct thorough research or consult a financial advisor before making investment decisions.
Kommentar:
Tuesday May 7, 2024
GRTS
Block Trade: GRTS 2.1M @ $1.01
Trade geschlossen: Stop wurde erreicht:
SL hit
Haftungsausschluss

Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.